Tag: Key

  • Writing Copy That Sells

    Every form of writing needs to be written with a different approach in order to create an impact on the reader. Most importantly, it is vital to showcase the benefits associated with your product or service through the write-up. Try to understand what problems the potential customer might be facing and then, with the help of your write-up, let them know how your product or service can help solve those problems. For example, while writing a sales copy you need to consider the key aspects of your product or service, which will not only help you in writing a good copy but also ensure its success in winning the sale…

    Read More
    http://www.associationofmarketing.org/articles/view.php?article_id=7637

    Views: 0

  • International working group on Ethics & COVID-19

    International working group on Ethics & COVID-19

    The response to the COVID-19 pandemic raises a number of difficult ethical issues, related to e.g. clinical trials, social distancing, priority-setting, health-care workers’ rights and obligations etc. WHO has established an international Working Group on Ethics & COVID-19 in order to develop advice on key ethical questions that Member States need to address.

    Related document

    Distilling existing guidance to support COVID-19 Research & Development [pdf, 263kb]

     

    International working group on Ethics & COVID-19
    Read More
    https://www.who.int/news-room/detail/20-03-2020-who-has-established-an-international-working-group-on-ethics-covid-19

    Views: 0

  • Oil Benchmark Slashed To $30 Per Barrel By Nigerian Government

    Oil Benchmark Slashed To $30 Per Barrel By Nigerian Government

    Oil Benchmark Slashed To $30 Per Barrel By Nigerian Government 3

    Oil Benchmark Slashed To $30 Per Barrel By Nigerian Government 4


     

    The Nigerian Government on Wednesday proposed $30 per barrel of oil so as to work the 2020 national budget around that.

    The announcement was made by the Minister of Finance, Zainab Ahmed, in Abuja.

    Ahmed advised a review of the 2020 budget using a $30 per barrel price benchmark in favour of the previous $57.

    She also said, “The privatisation proceeds will be cut by 50 per cent, based on the adverse economic outlook on sales of the Independent Power Projects and other assets.

    “The Federal Government is working on Fiscal Stimulus Measures to provide fiscal relief for taxpayers and key economic sectors.

    “We will incentivise employers to retain and recruit staff during the economic downturn.

    “We will stimulate investment in critical infrastructure; review non-essential tax waivers to optimise revenues, and compliment monetary and trade interventions to respond to the crisis.”

     

    Oil

    News

    AddThis

    : 

    Original Author

    : 

    SaharaReporters, New York

    Disable advertisements

    : 
    Oil Benchmark Slashed To $30 Per Barrel By Nigerian Government
    Read More
    http://saharareporters.com/2020/03/25/oil-benchmark-slashed-30-barrel-nigerian-government

    Views: 0

  • Should we anticipate a recession in 2019?

    Should we anticipate a recession in 2019?

    Vanguard Global Chief Economist Joe Davis shares his view that, despite concerns, key elements of the U.S. economy remain strong.
    Should we anticipate a recession in 2019?
    Read More
    https://investornews.vanguard/should-we-anticipate-a-recession-in-2019/

    Views: 0

  • Ensuring continuity of TB services during the COVID-19 pandemic

    Ensuring continuity of TB services during the COVID-19 pandemic

    GENEVA  As the world comes together to tackle the COVID-19 pandemic, it is important to ensure that essential health services and operations are continued to protect the lives of people with TB and other diseases or health conditions. Health services, including national programmes to combat TB, need to be actively engaged in ensuring an effective and rapid response to COVID-19 while ensuring that TB services are maintained.
     
    In the lead- up to World TB Day, Dr Tedros Adhanom Ghebreyesus, WHO Director-General emphasized in a news release, “COVID-19 is highlighting just how vulnerable people with lung diseases and weakened immune systems can be. The world committed to end TB by 2030; improving prevention is key to making this happen.”
     
    The World Health Organization (WHO) Global TB Programme, along with WHO regional and country offices, has developed an information note, in collaboration with stakeholders. This note is intended to assist national TB programmes and health personnel to urgently maintain continuity of essential services for people affected with TB during the COVID-19 pandemic, driven by innovative people-centred approaches, as well as maximizing joint support to tackle both diseases.
     
    “We stand in solidarity with those affected by COVID-19 and those at the frontlines of the fight to combat the disease,” said Dr Tereza Kasaeva, Director of the WHO Global TB Programme. “We need to act with urgency to ensure that in line with our vision of Health for All, no one with TB, COVID-19 or any health condition will miss out on the prevention and care they need.  It’s time for action.”

     

    Ensuring continuity of TB services during the COVID-19 pandemic
    Read More
    https://www.who.int/news-room/detail/24-03-2020-ensuring-continuity-of-tb-services-during-the-covid-19-pandemic

    Views: 0

  • World TB Day 2020: It’s Time for solidarity

    World TB Day 2020: It’s Time for solidarity

    At this unique time in history when the world is grappling with the COVID-19 pandemic, the WHO Department of Global HIV, Hepatitis and STI Programmes stands in solidarity with governments and communities as they seek to maintain health services
    and continue to address the needs of patients suffering from HIV and tuberculosis (TB). 

    Despite being preventable and treatable, tuberculosis remains the world’s biggest infectious killer and the leading cause of death among people living with HIV (PLHIV), responsible for 32% of the 770 000 lives lost to HIV in 2018. People
    living with HIV are far more vulnerable (nearly 20 times more) to TB infection than people without HIV and are three times more likely to die during TB treatment.  

    While there are proven interventions that reduce TB deaths – such as provision of TB preventive treatment, adoption of novel diagnostics for earlier TB diagnosis and linkage to treatment, and antiretroviral therapy (ART) – we are far behind
    in scaling these up, and diagnostic and treatment gaps remain, with only half of estimated TB cases among PLHIV reaching care in 2018, only half of estimated PLHIV with TB receiving ART, and less than half of PLHIV new on ART initiating TB preventive
    treatment in a subset of countries which reported globally.

    On this World TB Day, WHO highlights two key interventions to reduce unnecessary TB deaths among PLHIV: 

    • (1) provision of TB preventive treatment for all eligible PLHIV; and 
    • (2) increased uptake of newer diagnostic tests such as the lateral flow urine lipoarabinomannan assay (TB-LAM.) 

    As the new Director for the Department of Global HIV, Hepatitis and STI Programmes, I support current efforts to continue and to take to scale TB activities. It’s Time for solidarity!

    -Meg Doherty, Director Global HIV, hepatitis and STI Programmes, WHO

    HIV programmes are encouraged to ensure that TB preventive treatment, including shorter WHO-recommended regimens, with updated guidance launched today, are provided to all eligible PLHIV as part of a routine package of care, including provision of ART, and that treatment completion is ensured.   

    In recent months, WHO has also released guidelines for use of a bedside urine TB-LAM test to accelerate earlier TB diagnosis, with significantly expanded eligibility criteria. As this test is “point of care” with the potential for earlier
    TB diagnosis and treatment initiation, HIV programmes should consider these recommendations as they enhance strategies for TB diagnosis among PLHIV, including as part of a routine package of advanced HIV care. 

    It’s Time to urgently scale up TB preventive treatment and TB diagnosis and strengthen referral and linkages to TB treatment at HIV service delivery points in all countries and continue to scale-up ART among PLHIV with TB. This applies to all populations
    at risk, including children, pregnant women and marginalized groups, to ensure no one is left behind.

    WHO calls for continued collaboration in countries across health programmes for harmonized and integrated policies and service delivery, and engagement with communities and other sectors. Unless HIV programmes scale up interventions to close these
    gaps in prevention, diagnosis and treatment both for TB and HIV, countries and their development partners will not meet our common target: a 75% reduction in TB deaths among PLHIV between 2010 and 2020. HIV mortality cannot be reduced without addressing
    the leading cause: tuberculosis.

     

    World TB Day 2020: It’s Time for solidarity
    Read More
    https://www.who.int/news-room/detail/24-03-2020-world-tb-day-2020-it-s-time-for-solidarity

    Views: 0

  • WHO Information Note: Ensuring continuity of TB services during the COVID-19 pandemic

    WHO Information Note: Ensuring continuity of TB services during the COVID-19 pandemic

    As the world comes together to tackle the COVID-19 pandemic, it is important to ensure that essential health services and operations are continued to protect the lives of people with TB and other diseases or health conditions. Health services, including national programmes to combat TB, need to be actively engaged in ensuring an effective and rapid response to COVID-19 while ensuring that TB services are maintained.  

    In the lead- up to World TB Day, Dr Tedros Adhanom Ghebreyesus, WHO Director-General emphasized in a news release, “COVID-19 is highlighting just how vulnerable people with lung diseases and weakened immune systems can be. The world committed to end TB by 2030; improving prevention is key to making this happen.”  

    WHO Global TB Programme, along with WHO regional and country offices, has developed an information note, in collaboration with stakeholders. This note is intended to assist national TB programmes and health personnel to urgently maintain continuity of essential services for people affected with TB during the COVID-19 pandemic, driven by innovative people-centred approaches, as well as maximizing joint support to tackle both diseases.  

    “We stand in solidarity with those affected by COVID-19 and those at the frontlines of the fight to combat the disease,” said Dr Tereza Kasaeva, Director of the WHO Global TB Programme. “We need to act with urgency to ensure that in line with our vision of Health for All, no one with TB, COVID-19 or any health condition will miss out on the prevention and care they need. It’s time for action.”

     

    WHO Information Note: Ensuring continuity of TB services during the COVID-19 pandemic
    Read More
    https://www.who.int/news-room/detail/20-03-2020-who-information-note-ensuring-continuity-of-tb-services-during-the-covid-19-pandemic

    Views: 0

  • New WHO recommendations to prevent tuberculosis aim to save millions of lives

    Geneva –  New World Health Organization (WHO) guidance will help countries accelerate efforts to stop people with tuberculosis (TB) infection becoming sick with TB by giving them preventive treatment.

    A quarter of the world‘s population is estimated to be infected with TB bacteria. These people are neither sick nor contagious. However, they are at greater risk of developing TB disease, especially those with weakened immunity. Offering them TB
    preventive treatment will not only protect them from becoming sick but also cut down on the risk of transmission in the community.  

    As we mark World TB Day 2020, the disease remains the world’s top infectious killer. In 2018, 10 million people fell ill with TB worldwide and 1.5 million people lost their lives to this disease.

    “COVID-19 is highlighting just how vulnerable people with lung diseases and weakened immune systems can be,“ said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “The world committed to end TB by 2030; improving prevention is key
    to making this happen. Millions of people need to be able to take TB preventive treatment to stop the onset of disease, avert suffering and save lives”.

    Dr Tedros highlighted the importance to continue efforts to tackle longstanding health problems, including TB during global outbreaks such as COVID-19. At the same time, programmes already in place to combat TB and other major infectious diseases
    can be leveraged to make the response to COVID-19 more effective and rapid.

    Although some progress has been made towards targets set at the UN high-level Meeting on TB in 2018, TB preventive treatment has been largely neglected. Global leaders committed to ensuring access to TB preventive treatment to at least 24 million contacts
    of people with active TB and 6 million people living with HIV by 2022.  To date only a fraction of that target has been reached, with countries putting less than 430,000 contacts and 1.8 million people on TB preventive treatment in 2018.

    TB remains the top cause of death among people with HIV. TB preventive treatment works synergistically with antiretroviral therapy to prevent TB and save lives. Reinvigorated efforts by governments, health services, partners, donors and civil society
    will be needed to increase access to TB preventive treatment to the levels targeted.

    The new consolidated guidelines recommend a range of innovative approaches to scale up access to TB preventive treatment:

    • WHO recommends a scale-up of TB preventive treatment among populations at highest risk including household contacts of TB patients, people living with HIV and other people at risk with lowered” immunity or living in crowded settings.
    • WHO recommends an integration of TB preventive treatment services into ongoing case finding efforts for active TB. All household contacts of TB patients and people living with HIV are recommended to be screened
      for active TB. If active TB is ruled out, they should be initiated on TB preventive treatment.
    • WHO recommends that either a tuberculin skin test  or interferon-gamma release assay (IGRA) be used to test for TB infection. Both tests are helpful to find people more likely to benefit from TB preventive treatment
      but should not become a barrier to scale-up access. Testing for TB infection is not required before starting TB preventive treatment in people living with HIV, and children under 5 years who are contacts of people with active TB.
    • WHO recommends new shorter options for preventive treatment in addition to the widely used 6 months of daily isoniazid. The shorter options that are now recommended range from a 1 month daily regimen of rifapentine plus isoniazid
      to 3 months weekly rifapentine plus isoniazid, 3 months daily rifampicin plus isoniazid, or 4 months of daily rifampicin alone.

    “As people around the globe come together to commemorate World TB Day, WHO is calling on governments, affected communities, civil society organizations, health-care providers, donors, partners and the industry to unite forces and step up
    the TB response – notably for TB preventive treatment – to ensure no one is left behind,” said Dr Tereza Kasaeva, Director of WHO’s Global TB Programme. “The new WHO guidance shows the way forward for millions to rapidly
    access new tools and shorter, safer options for preventive treatment. The time for action is now.”

    TB preventive treatment is an affordable intervention that can prevent families from sliding into poverty and preserve the health and economy of whole communities. WHO anticipates that as new and safer drugs come onto the markets, and as prices
    fall, it will become a highly-cost effective way to save millions of lives.

     

    NOTES FOR EDITORS:

    WORK BY WHO AND PARTNERS

    WHO works closely with Member States including the US Government and technical and funding partners such as UNITAID to enhance access to shorter TB preventive treatment regimens. UNITAID-supported projects such as IMPAACT4TB and Cap-TB projects
    enabled by WHO with partners in Brazil, Cambodia, Cameroon, Côte d’Ivoire, Democratic Republic of Congo, Ethiopia, Ghana, India, Indonesia, Kenya, Lesotho, Malawi, Mozambique, South Africa, Uganda, United Republic of Tanzania and
    Zimbabwe are leading the way. The new treatment options are also now more affordable, thanks to the significant price drop of rifapentine – a key drug – facilitated recently by UNITAID, the Global Fund to Fight AIDS, Tuberculosis and Malaria
    and global biopharmaceutical company Sanofi, along with forthcoming arrangements underway with generic manufacturers.

    MORE ABOUT THE GUIDELINES

    The new consolidated WHO guidelines come with an operational handbook to help guide countries step-by-step as they take TB preventive treatment to scale. This includes guidance on how to prioritize and invest from demand creation for TB prevention
    to supervision and monitoring of the programme.

    The guidelines and operational handbook are also accompanied by an innovative mobile application – Prevent TB –to help health-care workers manage TB preventive treatment in their communities. Its online dashboard allows programme
    managers to visualize and monitor data in real time. The application can be customized by countries to suit their specific settings and is currently being adopted in India and Philippines.

    WORLD TB DAY

    The new guidelines and tools are being released ahead of World TB Day. World TB Day is observed on March 24 each year to raise public awareness and understanding about the world’s deadliest infectious killer – TB and its devastating
    health, social and economic impact on people around the world. Under the theme “It’s Time”, the spotlight this year is on urgently accelerating the TB response to save lives and end suffering.

    Read More
    https://www.who.int/news-room/detail/24-03-2020-new-who-recommendations-to-prevent-tuberculosis-aim-to-save-millions-of-lives

    Views: 0